Delivery Order SPE2DB24D3013-SPE2DB25FFNYG
Award Date 8/1/25
Potential Completion Date 8/22/25
Potential Value $13K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $25,121.56 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The order is for the supply of LUMAKRAS 320 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of September 12, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, leveraging its extensive supply chain network. The company has been...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Lumakras 320 mg tablets (90-count) under a firm fixed-price contract with a ceiling value of $13,491.97. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of August 13, 2025. The award is issued to AmerisourceBergen's Corporate Office division, headquartered in Conshohocken, Pennsylvania, which serves as the place of performance....
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a Delivery Order with a firm fixed price of $13,491.97 and a performance period through June 30, 2025. The contract is for the delivery of LUMAKRAS 320 MG TABLET 90S, a pharmaceutical product. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a $13,491.97 firm fixed-price delivery order contract awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of LUMAKRAS 320 MG TABLET 90S, a pharmaceutical product, with a completion date of June 20, 2025. AmerisourceBergen Drug Corp is a for-profit organization and a significant vendor for the DLA, holding a $999,999,999.00 Indefinite Delivery Contract (IDC) designated as SPE2DX to provide a wide...
- The Defense Logistics Agency Troop Support Medical awarded a $12,042.18 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 120 mg tablets of LUMAKRAS in 240 count bottles. The prime contractor will deliver the pharmaceutical products from its Conshohocken, Pennsylvania facility to support DLA Troop Support Medical programs. No major subcontractors or set aside designations were identified. This delivery order was issued on the agency's...
- The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $1,706.40 order is for the delivery of 60 tablets of the medication lacosamide 150 mg. The delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, which has a potential value of $999,999,999.00 and a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,624.35 to AmerisourceBergen Drug Corp for the supply of Lorbrena 100 mg tablets (30-count units) with an ultimate completion date of August 19, 2025. This is a firm fixed price contract with no set-aside designation, awarded competitively on July 29, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $9,599.25 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading pharmaceutical sourcing and distribution company. The contract is for the delivery of LONSURF 20 MG-8.19 MG tablets in 60-count packages, with a period of performance through April 2, 2024. AmerisourceBergen Drug Corp holds a larger indefinite delivery contract (IDC) with DLA worth up to $999,999,999.00...
- The Defense Logistics Agency awarded a delivery order valued at $4,349.27 to AmerisourceBergen Drug Corp for the supply of Linzess 145 microgram capsules (30-count units) with an ultimate completion date of July 31, 2025. This competitive award, issued on July 30, 2025, utilizes firm fixed pricing with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location....
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $28,486.52 to AmerisourceBergen Drug Corp on August 15, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price delivery order is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award represents a non-competitive set-aside...